Are recent clinical advances leading to controversies in airway diseases?
Aims : To evaluate the use of short-acting β-2 agonist (SABA) monotherapy versus maintenance and reliever therapy (MART) and triple therapy for asthma; to describe new treatments for chronic cough; to determine the optimal endoscopic procedure for different patients with chronic obstructive pulmonary disease (COPD) and asthma; to discuss the role of artificial intelligence in asthma and COPD treatment.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Nurse, Patient, Physician in Pulmonary Training
Endoscopy and interventional pulmonology, General respiratory patient care, Physiology